Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
Rocket Lab posted record Q2 revenue and backlog and keeps winning defense contracts, but shares remain volatile as investors await Neutron's fourth-quarter debut before re-rating the stock.
Read the full story at MarketBeat News Feed →